| Patents for C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924) |
|---|
| 02/11/1999 | WO1999006381A1 A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 02/11/1999 | WO1999006049A1 Integrin receptor antagonists |
| 02/11/1999 | CA2298544A1 Integrin receptor antagonists |
| 02/10/1999 | CN1207681A Sustained-release microgranules contg. diltiazem as active principle |
| 02/09/1999 | US5869697 Process for preparing diltiazem |
| 02/09/1999 | US5869483 Tricyclic benzazepine vasopressin antagonists |
| 02/04/1999 | WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 01/12/1999 | US5859241 Process for the preparation of a benzothiazepine |
| 01/12/1999 | US5859240 Reduction of imine group; oxidation; salt formation |
| 01/12/1999 | US5859239 Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepines and benzothiazepines |
| 01/05/1999 | US5856477 Hypotensive agents; congestive heart failure |
| 01/05/1999 | US5856476 Processes for preparing azepiones useful as intermediates in the preparation of inhibitors of angiotensin converting enzyme and neutral endopeptidase |
| 12/29/1998 | US5854274 Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 12/29/1998 | US5854236 Tricyclic benzazepine vasopressin antagonists |
| 12/29/1998 | US5854233 Method of treating liver disease and like indications with vasodilating agents |
| 12/17/1998 | WO1998056762A2 Process for preparing optically active phenyloxirane compounds |
| 12/17/1998 | CA2293404A1 Process for preparing optically active phenyloxirane compounds |
| 12/16/1998 | CN1202160A Compounds potentiating retinoid |
| 12/09/1998 | EP0882024A1 Retroviral protease inhibiting compounds |
| 12/08/1998 | US5847122 Process for preparing 1,5-benzothiazepine derivative |
| 12/08/1998 | US5846969 Tricyclic heterocyclic sulfonamide and sulfonic ester derivatives |
| 12/08/1998 | US5846967 Natriuretic and anti-hypertensive compounds |
| 12/01/1998 | US5843952 Tricyclic benzazepine vasopressin antagonists |
| 11/25/1998 | CN1199733A Process for preparing optically active trans-3-substituted glycidic acid ester |
| 11/18/1998 | CN1040751C Process for preparation of benzothiazepine derivs. |
| 11/10/1998 | US5834462 Antitumor agents; anticarcinogenic agents particularly for nasopharyngel, pulmonary, intestinal, mammary, uterus, gastric, ovarian or liver cancer and also leukemia |
| 10/29/1998 | WO1998047882A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| 10/29/1998 | CA2285664A1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists |
| 10/28/1998 | CN1197070A Process for preparing optically active phenylglycidyl acid derivative |
| 10/08/1998 | WO1998028268A3 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS |
| 10/07/1998 | EP0868184A1 Sustained-release microgranules containing diltiazem as the active principle |
| 10/07/1998 | CN1194979A Hypolipidemic 1,4-benzothiazepine-1, 1-dioxides |
| 10/06/1998 | US5817653 Endothelin receptor antagonists |
| 10/06/1998 | US5817652 Hypolipidaemic condensed 1,4-thiazepines |
| 09/24/1998 | WO1998041510A1 Novel benzolactam derivatives and medicinal compositions comprising the same |
| 09/22/1998 | US5811422 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 09/16/1998 | EP0864582A2 Hypolipidemic 1,4-benzothiazepine-1,-dioxides |
| 09/03/1998 | WO1998038182A1 Hypolipidemic bicyclic derivatives |
| 09/02/1998 | EP0861834A1 Process for preparing optically active trans-3-substituted glycidic acid ester |
| 09/02/1998 | EP0861250A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 08/27/1998 | CA2230299A1 Process for preparing optically active trans-3-substituted glycidic acid ester |
| 08/26/1998 | EP0860439A1 Process for preparing an optically active phenylglycidyl acid derivative |
| 08/21/1998 | CA2228196A1 Process for preparing an optically active phenylglycidyl acid derivative |
| 08/20/1998 | WO1998035941A1 New benzolactam derivatives and medicinal compositions containing the same |
| 08/20/1998 | WO1998035939A1 Malonic diamide derivatives and use thereof |
| 08/19/1998 | EP0858999A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 08/18/1998 | CA2037298C Processes for preparing 1,5-benzothiazepine derivatives |
| 07/28/1998 | US5786353 Tricyclic benzazepine vasopressin antagonists |
| 07/14/1998 | CA2025226C Process for preparing optically active 3-phenylglycidic acid esters |
| 07/08/1998 | CN1039008C Dual action inhibitors in angiotensin invertase and neutral endopeptidase |
| 07/02/1998 | WO1998028268A2 CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AS β-AMYLOID PEPTIDE RELEASE INHIBITORS |
| 07/02/1998 | CA2272305A1 Cycloalkyl, lactam, lactone and related compounds as .beta.-amyloid peptide release inhibitors |
| 06/24/1998 | EP0848703A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
| 06/23/1998 | US5770594 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors |
| 06/16/1998 | CA2042535C Process for the preparation of intermediates useful for the synthesis of benzothiazepines |
| 06/02/1998 | US5760221 Subjecting 1,8-dicarboxylic acid ester to dieckmann condensation reaction |
| 06/02/1998 | US5760031 Kidney diseases |
| 05/19/1998 | US5753642 Agriculture, medicine |
| 05/05/1998 | US5747487 Tricyclic benzazepine vasopressin antagonists |
| 04/16/1998 | WO1998015278A1 Method for stimulating bone formation |
| 04/15/1998 | EP0799220A4 Polymerisable monomers and polymers |
| 04/14/1998 | US5739128 Administering for treatment of diseases characterized by excess renal reabsorption of water |
| 04/09/1998 | WO1998014433A1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 04/07/1998 | US5736538 Treats in mammal the disease characterized by excess renal reabsorption of water, is congestive heart failure, nephrotic syndrome, hyponatremia, coronary and renal vasospasm, cardiac ischemia, liver cirrhosis and brain edema |
| 04/01/1998 | EP0832879A1 Process for preparing intermediates for thrombin inhibitors |
| 03/20/1998 | CA2185950A1 Process for preparing intermediates for thrombin inhibitors |
| 03/11/1998 | EP0667866B1 1,4-benzothiazepines useful as neurological agents |
| 03/05/1998 | WO1998008827A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008823A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | WO1998008505A1 Pharmaceutical compounds |
| 03/05/1998 | CA2264045A1 Heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263932A1 1,4-heterocyclic metalloprotease inhibitors |
| 03/05/1998 | CA2263917A1 Heterocyclic metalloprotease inhibitors |
| 03/04/1998 | EP0826678A1 Process for preparing optically active benzothiazepine compound, and intermediate therefor |
| 03/04/1998 | CN1174837A Process for preparing optically active benzothiazepine compound, and intermediate therefor |
| 03/03/1998 | US5723602 Angiotensin converting enzyme and endopeptidase inhibitors, cardiovascular disorders |
| 03/03/1998 | US5723458 1,4-benzothiazepines |
| 03/03/1998 | US5723457 Acylmercaptoalkanoylamino and mercaptoalkanoylamino benzazepines |
| 02/12/1998 | WO1998005657A1 2,3-dihydro-1,4-benzothiazepines, their preparation and their use as intermediates |
| 01/15/1998 | WO1998001417A1 Calcium receptor-active compounds |
| 01/15/1998 | WO1998001164A1 Tricyclic radiolabeled d4 receptor ligands |
| 01/06/1998 | US5705638 Process for preparing optically active 3-hydroxy-1,5-benzothiazepine derivative and intermediate therefor |
| 12/31/1997 | CN1168878A Process for preparing optically active 2-halogeno-3-hydroxypropionic acid ester |
| 12/31/1997 | CN1168792A Matrix table allowing prolonged release of sodium salt of tianeptine after administration by oral route |
| 12/30/1997 | CA2142707C Benzo-fused lactams promote release of growth hormone |
| 12/29/1997 | EP0814080A1 Squalene synthetase inhibitors |
| 12/24/1997 | WO1997048396A1 A method of treating liver disease and like indications with vasodilating agents |
| 12/24/1997 | CA2258696A1 A method of treating liver disease and like indications with vasodilating agents |
| 12/20/1997 | CA2208174A1 Squalene synthetase inhibitors |
| 12/18/1997 | WO1997047625A1 Tricyclic benzazepine vasopressin antagonists |
| 12/16/1997 | US5698691 Condensed cyclic compounds and their use |
| 12/02/1997 | US5693636 Bicyclic fibrinogen antagonists |
| 12/02/1997 | US5693635 Tricyclic benzazepine vasopressin antagonists |
| 11/26/1997 | EP0808824A2 Process for preparing optically active 2-halogeno-3-hydroxypropionic acid ester |
| 11/12/1997 | CN1164856A Novel alkylamino derivatives as sigma 2 selective ligands |
| 11/11/1997 | US5686445 Pyridobenzoxazepine and pyridobenzothiazepine vasopressin antagonists |
| 11/05/1997 | CN1164230A Hypolipidemic benzothiazepines |
| 10/29/1997 | EP0803253A1 Matrix-type oral sustained-release tablets containing tianeptine sodium salt |